Parvodicine C3

Parvodicin C3 is a glycopeptide antibiotic. Parvodicin C3 has inhibitory effect on Staphylococcus aureus, Staphylococcus furfur, Staphylococcus hemolyticus and Enterococcus faecalis[1].

110882-86-5

12352005

Antibiotic; Bacterial

Anti-infection

COVID-19-immunoregulation

Infection

OC1=CC=C(C(NC)C(NC(CC2=CC=C(OC3=C(O[C@H]4[C@H](NC(CCCCCCCCC(C)C)=O)[C@@H](O)[C@H](O)[C@@H](C(O)=O)O4)C(OC5=CC=C6C=C5Cl)=CC7=C3)C=C2)C(NC8C(NC7C(NC(C9=CC(C%10=C%11C=C(O)C=C%10O[C@@H]%12[C@@H](O)[C@@H](O)[C@H](O)[C@@H](COC(C)=O)O%12)=C(O)C=C9)C(NC(C6O)C(NC%11C(O)=O)=O)=O)=O)=O)=O)=O)C=C1OC%13=CC8=C(Cl)C(O)=C%13

C85H90Cl2N8O30

1774.57

[1]S B Christensen, et al. Parvodicin, a novel glycopeptide from a new species, Actinomadura parvosata: discovery, taxonomy, activity and structure elucidation. J Antibiot (Tokyo) . 1987 Jul;40 (7) :970-90.

Room temperature

http://file.medchemexpress.com/batch_PDF/HY-N5181/

Natural Products

No Development Reported